These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11220889)

  • 1. [Spirapril in patients with hypertension: clinical experience in Germany].
    Schmidt J; Kraul H
    Ter Arkh; 2000; 72(10):90-4. PubMed ID: 11220889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of mild and moderate hypertension with enalapril (multicenter study of enap and enap N in Ukraine)].
    Dziak GV; Kolomiets SN; Minakov AI; Fushteĭ IM; Iavorskiĭ OG; Bekker VF; Vankhanen VN; Davydova IV; Zaĭtseva VI; Kolesnik TV; Kolomiets VV; Svishchenko EP; Taran AI; Shlykova NA; Barbich-Zhagar B
    Ter Arkh; 1999; 71(1):31-4. PubMed ID: 10097297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE-inhibitor therapy with spirapril increases nocturnal hypotensive episodes in elderly hypertensive patients.
    Kantola I; Terént A; Kataja M; Breig-Asberg E
    J Hum Hypertens; 2001 Dec; 15(12):873-8. PubMed ID: 11773991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of quadropril (spirapril) vs capropril in treatment of essential hypertension].
    Polimbetov DS; Kraĭsman VA; Isaeva BG; Aliev FR
    Ter Arkh; 2000; 72(10):94-6. PubMed ID: 11220890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.